GB2500423B - Red Sea Sponge Amorphinopsis extracts and uses thereof - Google Patents
Red Sea Sponge Amorphinopsis extracts and uses thereofInfo
- Publication number
- GB2500423B GB2500423B GB1205031.6A GB201205031A GB2500423B GB 2500423 B GB2500423 B GB 2500423B GB 201205031 A GB201205031 A GB 201205031A GB 2500423 B GB2500423 B GB 2500423B
- Authority
- GB
- United Kingdom
- Prior art keywords
- amorphinopsis
- extracts
- red sea
- sea sponge
- sponge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000765162 Amorphinopsis Species 0.000 title 1
- 239000000284 extract Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1205031.6A GB2500423B (en) | 2012-03-22 | 2012-03-22 | Red Sea Sponge Amorphinopsis extracts and uses thereof |
EP13721092.8A EP2836222A1 (en) | 2012-03-22 | 2013-03-21 | Extract from the sponge amorphinopsis |
PCT/IB2013/052249 WO2013140364A1 (en) | 2012-03-22 | 2013-03-21 | Extract from the sponge amorphinopsis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1205031.6A GB2500423B (en) | 2012-03-22 | 2012-03-22 | Red Sea Sponge Amorphinopsis extracts and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201205031D0 GB201205031D0 (en) | 2012-05-09 |
GB2500423A GB2500423A (en) | 2013-09-25 |
GB2500423B true GB2500423B (en) | 2016-10-26 |
Family
ID=46086922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1205031.6A Expired - Fee Related GB2500423B (en) | 2012-03-22 | 2012-03-22 | Red Sea Sponge Amorphinopsis extracts and uses thereof |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2836222A1 (en) |
GB (1) | GB2500423B (en) |
WO (1) | WO2013140364A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005026169A1 (en) * | 2003-09-15 | 2005-03-24 | The University Of British Columbia | Ceratamines a and b, and analogues, syntheses and pharmaceutical compositions thereof |
US20090093513A1 (en) * | 2007-10-09 | 2009-04-09 | Hamann Mark T | Method to Use Compositions Having Antidepressant Anxiolytic and Other Neurological Activity and Compositions of Matter |
WO2010014240A2 (en) * | 2008-07-29 | 2010-02-04 | The Regents Of The University Of California | Novel bioactive small molecules derived from sea sponges |
-
2012
- 2012-03-22 GB GB1205031.6A patent/GB2500423B/en not_active Expired - Fee Related
-
2013
- 2013-03-21 WO PCT/IB2013/052249 patent/WO2013140364A1/en active Application Filing
- 2013-03-21 EP EP13721092.8A patent/EP2836222A1/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005026169A1 (en) * | 2003-09-15 | 2005-03-24 | The University Of British Columbia | Ceratamines a and b, and analogues, syntheses and pharmaceutical compositions thereof |
US20090093513A1 (en) * | 2007-10-09 | 2009-04-09 | Hamann Mark T | Method to Use Compositions Having Antidepressant Anxiolytic and Other Neurological Activity and Compositions of Matter |
WO2010014240A2 (en) * | 2008-07-29 | 2010-02-04 | The Regents Of The University Of California | Novel bioactive small molecules derived from sea sponges |
Non-Patent Citations (5)
Title |
---|
Actual Biol; Vol 33, pp 173-181 (2001). Montano-Castaneda & Santafe-Patino. "Evaluation of the antioxidant activity of marine sponges from the columbian caribbean" * |
J Exp Mar Biol Ecol; Vol 313, pp 125-137 (2004). Prado et al. "Effects of marine organisms extracts on microtubule integrity and cell cycle progression in cultured cells" * |
J Nat Prod; Vol 65, pp 2-6 (2002). Youssef et al. "Salmahyrtisol A, a novel seterpernene from the red sea sponge Hyrtios erecta" * |
Pharmacogos Res; Vol 4, pp 63-66 (2012). Tabares et al. "Identification of the protease inhibitor miraziridine A in the red sea sponge Theonella swinhoei" Available online at: http://www.phcogres.com/article.asp?issn=0974-8490;year=2012;volume=4;issue=1;spage=63;epage=66;aulast=Tabares * |
Tetrahedron; Vol 62, pp 10393-10399 (2006). Wegerski et al. "Stereochemical challenges in characterizing nitrogenous spiro-axane sesquiterpenes from the Indo-Pacific sponges Amorphinopsis and Axinyssa" * |
Also Published As
Publication number | Publication date |
---|---|
EP2836222A1 (en) | 2015-02-18 |
GB201205031D0 (en) | 2012-05-09 |
WO2013140364A1 (en) | 2013-09-26 |
GB2500423A (en) | 2013-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1199023A1 (en) | Substituted benzothienylpyrrolotriazines and uses thereof | |
HK1200822A1 (en) | Substituted dipyridylamines and uses thereof | |
HK1203493A1 (en) | Substituted azabicycles and use thereof | |
HK1202545A1 (en) | New diazaspirocycloalkane and azaspirocycloalkane | |
EP2822592A4 (en) | Tgf- 1 specific antibodies and methods and uses thereof | |
IL239369A0 (en) | Pirocyclic morphinans and their use | |
HK1210949A1 (en) | Combinations and uses thereof | |
IL234756A0 (en) | Immunomodulatory agent and uses therefor | |
SG11201501646PA (en) | Peptides and their uses | |
HK1203198A1 (en) | Substituted phenylimidazopyrazoles and use thereof | |
EP2887928A4 (en) | Retinoids and use thereof | |
HK1210809A1 (en) | Beta-hexosyl-transferases and uses thereof | |
HK1201050A1 (en) | Polypeptides and their use | |
PL2858655T3 (en) | Thyme extracts and their use | |
IL237400B (en) | Rhizobacteria and uses thereof | |
PL2830641T3 (en) | New valerian extracts and uses thereof | |
HK1207154A1 (en) | C1q-adiponectin complex and use thereof c1q- | |
GB2500423B (en) | Red Sea Sponge Amorphinopsis extracts and uses thereof | |
PT2760880E (en) | Peptidomimetics and their application | |
GB201222541D0 (en) | Kiddibidet and pottibidet | |
IL218974A0 (en) | Conaction bitwen coutch and playels | |
GB201202021D0 (en) | Co-sleeper and breastfeeder | |
GB201215414D0 (en) | Composition and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20200322 |